NCT00457847 Identifying Genetic Characteristics That Increase Risk of Primary Graft Dysfunction Following Lung Transplantation Status ACTIVE_NOT_RECRUITING Phase N/A
NCT00447330 Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma Status COMPLETED Phase PHASE2
NCT00427193 CALERIE: Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy Status COMPLETED Phase NA
NCT00425815 Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia Status WITHDRAWN Phase PHASE2
NCT00417742 Project CHEER (Comprehensive Headache Evaluation, Education, Relief) Status COMPLETED Phase NA
NCT00405678 Exercise Intervention Study for Early-Stage Breast Cancer Patients Receiving Neoadjuvant Therapy. Status COMPLETED Phase PHASE1/PHASE2
NCT00402480 Hydroxyurea to Prevent Stroke in Children With Sickle Cell Anemia and Elevated TCD Flow Velocity Status COMPLETED Phase PHASE2
NCT00399893 Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS) Status TERMINATED Phase NA
NCT00387933 Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma Status COMPLETED Phase PHASE1
NCT00374738 Effects of an Alternative Treatment for Military Sexual Trauma on PTSD Symptoms, Neurosteroids and Brain Function Status COMPLETED Phase NA
NCT00369603 Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients Status TERMINATED Phase PHASE4
NCT00362921 Gliadel Wafer and O6-Benzylguanine in Treating Patients With Recurrent Glioblastoma Multiforme Status COMPLETED Phase PHASE2
NCT00354913 Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma Status COMPLETED Phase PHASE2
NCT00354068 Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma Status COMPLETED Phase PHASE1